Connect with Us
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2024 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.
Standards and Guidance powerpoint and templates for Medical Affairs strategic planning
This paper synthesizes the views of senior global Medical Affairs leaders to provide a unified vision for the future of Medical Affairs. As such, this document represents the first consensus position by executives in Medical Affairs of our evolving roles, activities, and value in society, industry, teams and as individuals (detailing each in turn). By 2030, Medical Affairs will solidify its transition from executional to strategic, and the function will come to represent the voice of the patient within industry. We will not only disseminate evidence but also lead evidence generation activities that inform the real-world use of marketed and emerging treatments. Also in this time frame, we will solidify the role of Medical Affairs as industry’s external earpiece, gleaning insights from our interactions with the health care ecosystem that drive understanding of patient, payer, and provider needs and opinions. Throughout this evolution, the true north of Medical Affairs remains the same: to ensure that our science and technologies benefit patients.
This webinar will provide an overview of the evolution of the Medical Affairs role and contributions to scientific congresses. We will revisit the good old days of in person congress engagement pivoting to highlight the innovations scientific exchange today. We will also discuss the elements of transitioning to a completely virtual platform due to the COVID-19 pandemic which provided an opportunity to re-evaluate the medical affairs approach. Which activities and educational resources were of high-value and could be improved upon further? Lastly, we will touch upon future congresses experiences. What will HCP engagement consist of– live, virtual, hybrid, etc. Based upon these new opportunities are our metrics and KPIs effective?
1. Identify opportunities to leverage the congress experience to enhance scientific exchange
2. Explore strategies to harmonize in-person and digital medical affairs engagement
At the MAPS 2022 Global Annual Meeting, we sat down with Riad Dirani, Vice President of Global Health Economics and Outcomes Research at Teva Pharmaceuticals, and Omar Dabbous, Vice President of Global Health Economics and Outcomes Research and Real World Evidence at AveXis to chat about the structure and activities of HEOR within Medical Affairs.
MAPS speaks with Tim Mikhelashvili and Riaz Abbas about innovative approaches to compliant patient education including collaborations with patient associations, peer navigators and the emerging use of social media.
MAPS members represent the full range of Medical Affairs professionals, from those leading or working in large organizations, to those tasked with starting a Medical Affairs function at startup or emerging organizations. Here, MAPS speaks with Lobna Salem, Regional Chief Medical officer Developed Markets& Japan Australia and New Zealand at Viatris, about the process of building Medical Affairs from scratch.
This white paper is inspired by an inquiry to the Medical Affairs Professional Society (MAPS) Digital Focus Area Working Group (FAWG) requesting guidance on best practices to establish a digital framework within Medical Affairs at a small pharmaceutical company. While this paper seeks to provide this specific guidance, the digital framework described herein is not only applicable to small organizations but can be seen as a basic digital framework for Medical Affairs teams in biopharmaceutical and MedTech organizations of any size.
Digital tools power the ability of Medical Affairs teams to generate, analyze and disseminate data to external stakeholders across the product lifecycle, while at the same time bringing essential learnings from these stakeholders back to the organization in the form of insights. That said, no single digital structure or set of digital tools will be appropriate for all organizations. Thus, rather than considering the recommendations of this paper a one-size-fits-all system, it is important to evaluate how digital transformation may empower and support a company’s core beliefs and key messages.
Importantly, no matter the specifics of implementation, we recommend a vision-first approach to digital – only once an organization’s vision has been established is it appropriate or even possible to successfully define the digital pillars needed to implement and execute this vision.
Once a company’s vision is clear, Medical Affairs teams may consider the core components of developing a Medical Affairs digital strategy and plan shown in Figure 1, each of which will be discussed in turn.
Pharmaceutical companies continue to evolve the way they operate, both internally and within the external environment. A variety of factors drive this evolution including societal expectations, continued changes in healthcare systems across geographies, advances in digital technology and its application (as highlighted during COVID 19), and complex legal, regulatory, compliance, and privacy obligations. As a result of these factors, the Medical Affairs (MA) function will become increasingly critical due to its unique positioning, as follows:
This paper explores the MA-based medical insights function and insights-related activities from an MA operational perspective, and identifies basic operational elements required to establish medical insights as a core strategic MA function.
Medical Affairs is a function within the biopharmaceutical, consumer healthcare, and MedTech industries that sits alongside other functions including Research & Development (R&D) and Commercial as one of the strategic pillars of the industry. R&D develops new drugs, devices and diagnostics; Commercial markets and sells these products; and Medical Affairs generates and communicates data that help healthcare professionals (HCPs), payors, policy makers and others make informed decisions that ensure the best use of treatments to benefit patients. In this way, Medical Affairs plays a vital role in providing scientific evidence and understanding to appropriately change clinical practice.
Just as there are many roles within R&D and Commercial, individuals working within Medical Affairs are responsible for many activities, especially including the following:
At the MAPS 2022 Global Annual Meeting, MAPS sits down to chat with José Borbolla, Global Executive Medical Director at Esai, and Augusto Grinspan, VP Medical Affairs and Head LATAM with Merck KGaA about developments in the practice and direction of Medical Affairs in Latin America. Augusto and José are also co-chairs of the MAPS Latin America Chapter.
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2024 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.